The Ralph T. and Esther L. Warburton Foundation and Dr. Hugh Judge Jewett Fellowship in Urologic Oncology
The Ralph T. and Esther L. Warburton Foundation and Dr. Hugh Judge Jewett Fellowship in Urologic Oncology at the Brady Urological Institute is approved by the Society of Urologic Oncology (S.U.O). The fellowship provides comprehensive multidisciplinary training in all aspects of urologic cancer surgery, including open, laparoscopic, and robotic-assisted techniques for disease management. Our goal is to train future leaders in academic urologic oncology to make significant contributions to the field.
The Urologic Oncology Fellow will have an opportunity to work directly with research faculty and clinicians who diagnose and manage urologic malignancies using the most up-to-date clinical and research skills. Our surgeons perform open and minimally-invasive surgical procedures for the treatment of all urological malignancies and work closely with fellowship trainees. The fellow is appointed as Instructor in Urology with full hospital admitting, operative, and clinic privileges.
The program is a two-year fellowship that includes one year of clinical urologic oncology and one year of oncologic research. The fellowship is only open to United States citizens. We accept one applicant per year through the SUO match program http://suonet.org/fellowships/
**NOTE: We are accepting applications for a Fellow to begin on July 1, 2018.**
Areas of surgical training include:
- Prostate cancer - open radical retropubic and robotic laparoscopic radical prostatectomy, transperitoneal and extraperitoneal approaches; cryoablation
- Kidney cancer - open partial/radical nephrectomy including IVC thrombectomy; laparoscopic radical nephrectomy; robotic partial nephrectomy
- Urothelial cancer - open and robotic radical cystectomy; orthotopic neobladder reconstruction and continent urinary reconstruction (conduit, pouch, neobladder); open, laparoscopic and robotic nephroureterectomy; partial cystectomy, TURBT
- Testis cancer – orchiectomy; open and robotic RPLND
Areas of research training include:
- Prostate – active surveillance, serum and urinary biomarkers, genomics, high-risk disease, adjuvant therapy, advanced imaging, neoadjuvant clinical trials, MRI-guided biopsy, intraoperative imaging, epidemiology, outcomes
- Kidney – active surveillance, biomarkers, ablation, outcomes, targeted therapy, in vivo imaging
- Bladder – tissue engineering, high risk disease, biomarkers